Kum Kang Kind Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
56,210
53,777
47,847
50,997
63,001
Total Accounts Receivable
145,555
146,667
140,024
151,569
159,195
Inventories
79,197
84,389
77,953
62,304
81,193
Other Current Assets
2,698
3,175
7,654
3,452
3,342
Total Current Assets
283,660
288,008
273,478
268,323
306,730
Net Property, Plant & Equipment
345,159
387,688
320,110
355,012
361,859
Total Investments and Advances
35,377
36,674
70,384
74,827
76,509
Long-Term Note Receivable
553
316
3,995
481
372
Intangible Assets
8,402
10,462
10,373
9,315
9,338
Other Assets
2,304
-
-
2,847
1,613
Total Assets
675,455
723,147
678,341
710,806
756,422
ST Debt & Current Portion LT Debt
241,502
231,005
285,356
244,101
293,333
Accounts Payable
77,749
55,205
38,400
47,233
43,785
Income Tax Payable
5,405
2,720
3,328
9,209
8,068
Other Current Liabilities
30,648
40,669
36,261
37,892
44,460
Total Current Liabilities
355,303
329,599
363,345
338,435
389,645
Long-Term Debt
40,866
96,495
27,629
51,630
23,746
Provision for Risks & Charges
2,650
3,156
2,686
607
628
Deferred Taxes
15,965
16,122
11,510
12,447
8,402
Other Liabilities
3,331
3,169
3,213
2,887
2,894
Total Liabilities
418,115
448,540
408,383
406,007
425,316
Common Equity (Total)
213,265
227,007
226,416
256,615
272,534
Total Shareholders' Equity
213,265
227,007
226,416
256,615
272,534
Total Equity
257,340
274,607
269,958
304,798
331,107
Liabilities & Shareholders' Equity
675,455
723,147
678,341
710,806
756,422
Accumulated Minority Interest
44,075
47,600
43,542
48,184
58,573

About Kum Kang Kind Co.

View Profile
Address
110 Dasan-ro
Busan BU 49489
Korea, Republic Of
Employees -
Website http://www.kumkangkind.com
Updated 07/08/2019
Kumkang Kind Co., Ltd. engages in the manufacture of pipes and tubes of non-cast iron or steel. It operates through following business divisions: Steel Pipe, Scaffold, Panel, Animal Feed, and Other. The Steel Pipe business supplies black pipe, white pipe, CGI, and OCTG.